Log in to your Inderes Free account to see all free content on this page.
Flerie
35.10 SEK
+0.29 %
Less than 1K followers
FLERIE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Flerie
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 0.0 | 97.5 | 0.1 | |||
| growth-% | -60.2 % | -99.9 % | |||||
| EBITDA | -86.8 | -56.2 | -101.7 | -102.2 | -106.2 | -274.2 | -699.5 |
| EBIT | -87.7 | -57.3 | -102.9 | -103.2 | -107.4 | -275.0 | -700.1 |
| Profit before taxes | -87.8 | -57.4 | -103.0 | -100.3 | -95.3 | -227.9 | -757.9 |
| Net income | -87.8 | -57.4 | -103.0 | -100.3 | -95.3 | -228.0 | -756.9 |
| EPS | -44.63 | -24.25 | -19.34 | -19.00 | -18.00 | -3.24 | -9.71 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -98,605.7 % | -160,448.6 % | -108.9 % | -274,200.0 % | |||
| EBIT-% | -99,672.7 % | -163,854.3 % | -110.1 % | -275,000.0 % | |||
| ROE | -82.4 % | -116.4 % | -23.7 % | -30.0 % | -39.9 % | -5.4 % | -22.4 % |
| ROI | -68.0 % | -93.8 % | -23.1 % | -28.6 % | -31.8 % | -5.4 % | -22.3 % |
Login required
This content is only available for logged in users